Investment
Features
FeesSafety
Academy
More
Pluang+

RENK posts record €1.2B H1 orders, EBIT up 10%, confirms 2026 outlook

Company Fundamentals
06 Aug 2026
Renk Group Ag
View Source
Bullish
pluang ai news

RENK Group AG reported a record €1.2 billion in orders for the first half of 2026, a 29.7% increase from the previous year, driven by strong demand in defense. The company achieved its highest-ever quarterly order intake of €612.8 million in Q2, with a book-to-bill ratio of 1.9x and an all-time high order backlog of €7.4 billion. Revenue rose 2.7% to €637.2 million, while adjusted EBIT grew 10.1% to €98.2 million, improving the EBIT margin to 15.4%. RENK confirmed its full-year guidance of over €1.5 billion in revenue and adjusted EBIT between €255 million and €285 million, supported by ongoing investments and strategic acquisitions like David Brown Defence.

More News

Credit card balances overdue by 90 days have nearly doubled since 2022, while new delinquencies remain steady.

Credit card balances overdue by 90 days have nearly doubled since 2022, while new delinquencies remain steady.

Since 2022, the amount of credit card debt that is 90 days overdue has almost doubled, indicating growing financial stress among borrowers. However, the rate of new delinquencies has not increased, suggesting that while existing overdue balances are ...

Market News
Neutral
3 hours ago
Class action lawsuit filed against Replimune over misleading FDA data submissions

Class action lawsuit filed against Replimune over misleading FDA data submissions

Schall, Brown & Schwartz LLP announced a class action lawsuit against Replimune Group for allegedly making false and misleading statements about its Biologics License Application (BLA) to the FDA. The company reportedly submitted incomplete and unpla...

Market News
Bearish
4 hours ago
Class action lawsuit filed against Replimune over misleading FDA study claims

Class action lawsuit filed against Replimune over misleading FDA study claims

Replimune Group faces a class action lawsuit alleging violations of securities laws due to false and misleading statements about its FDA study design in its Biologics License Application. The lawsuit covers shareholders who bought Replimune shares be...

Market News
Bearish
4 hours ago
Nvidia shares jump 6% premarket as AI demand outlook beats expectations

Nvidia shares jump 6% premarket as AI demand outlook beats expectations

Nvidia's shares rose nearly 6% in premarket trading after the company reported earnings that exceeded expectations and provided strong revenue guidance. CEO Jensen Huang highlighted that AI demand has reached an inflection point, with a significant i...

Company Fundamentals
Bullish
4 hours ago
Faster payments require smarter controls to balance speed, fraud risk, and regulatory compliance.

Faster payments require smarter controls to balance speed, fraud risk, and regulatory compliance.

WEX highlights that the rise of embedded payments, instant payment rails, and AI is transforming payments from a simple expense to a key driver of business growth and product strategy. However, faster payments increase fraud risk and reduce time for ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App